Medicaid expansion under the ACA improved long-term survival for younger adults with operable lung cancer, despite no earlier ...
News-Medical.Net on MSN
Durvalumab extends survival in small cell lung cancer but raises cost concerns
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...
“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...
Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of ...
The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...
News Medical on MSN
Liquid Biopsies Boost Lung Cancer Mutation Detection
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
GlobalData on MSN
MSD begins KANDLELIT-007 trial of calderasib for NSCLC
Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback